Mr Simon Brewster

Simon Brewster is a senior Consultant Urologist and prostate gland specialist in Oxfordshire. Simon specialises in prostate cancer and other prostate disease (PSA kinetics, benign prostatic hyperplasia (BPH), prostatitis). He is trained as a general urologist and treats a variety of conditions including urinary tract symptoms, blood in the urine (haematuria), bladder cancer and recurrent urinary infections.

Simon qualified in medicine at Charing Cross Hospital in 1986, with honours in Pathology and a 1st class Bsc. degree in Anatomy. He moved to Bristol to train in surgery and specialised in urology. He developed his interest in prostate disease, having spent two years in full-time laboratory research, leading to the award of his MD doctorate thesis in 1993. In 1997 he attained the FRCS (Urology) and went to John Hopkins Hospital, Baltimore to develop expertise in radical prostatectomy with Dr Patrick Walsh.

In 1998, Simon was appointed as a consultant in Oxford, where he pioneered the prostate cancer diagnostic and active surveillance services, radical prostatectomy, and Holmium laser enucleation of the prostate (HoLEP). He has led on prostate cancer service provision and clinical governance for the NHS urology department in Oxford. He was Chair of the Thames Valley Cancer Network Urology steering group 2008-13, with responsibilities to advise commissioners and ensure equal provision of regional NHS cancer services. He is currently serving as an elected clinical staff Governor of the Oxford University Hospitals NHS Foundation Trust.

Simon contributes to the content of several patient information booklets and webpages produced by Prostate Cancer UK and helped to found the Oxfordshire Prostate Cancer Support Group in 2010. He is a member of the British Association of Urological Surgeons (BAUS) and the American Urological Association (AUA).

As of January 2018, he trained to perform the NICE-approved “SpaceOAR” gel injection (IPG590) for patients about to undergo beam radiotherapy for prostate cancer at GenesisCare.

As of January 2019 he trained to provide the NICE-approved Rezum daycase procedure (MIB158) – ablation of BPH/ prostate enlargement using steam for self-pay and insured patients, as well as the highly-acclaimed Holmium laser prostate enucleation (HoLEP).